IBD’s Chronic Nature May Be Due to Long-Lived Immune Cell
New findings may provide new therapeutic target and help explain why IBD and other autoimmune diseases are often chronic and life-long
New findings may provide new therapeutic target and help explain why IBD and other autoimmune diseases are often chronic and life-long
A British-based cell therapy company is using smart operations to streamline its viral vector processing.
CMS proposed Medicare’s CGT reimbursement policy matches Medicaid’s sickle cell disease policy, forming a unified government approach.
Prodigiosin applications extend from manufacturing pigment and environmental-control agent to antibiotic and potential oncology drug.
Insilico Medicine is heading to the clinic with a treatment for methylthioadenosine phosphorylase (MTAP) deleted cancers.
New data-intensive platforms continue to leverage artificial intelligence tools for improved speed and failure rate reductions for drug discovery.
The mini colons replicate both the physical structure and cellular diversity in the colon in both healthy and diseased states.
Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
Workflow design and data management are pivotal components of cell and gene therapy research and development. Advances in artificial intelligence, informatics, and automation have made…
ASO-therapy rescues defects in preclinical Timothy syndrome models, a neurodevelopmental disorder with significant morbidity and mortality.
Possibilities include the classification of malignancies, the development of anti-obesity drugs, and the reprogramming of cells to reverse age-related diseases.